Neeta Tandon, MA

home / authors / neeta-tandon-ma

Articles

Site Logo

Direct and Indirect Cost Burden of Chronic Hepatitis C

Neeta Tandon, MA;K. Rajender Reddy, MD;Luis A. Balart, MD;John Fastenau, MPH, RPh;Patrick Lefebvre, MA;Hélène Parisé, MA;François Laliberté, MA;Dominic Pilon, MA;Mei Sheng Duh, MPH, ScD
September 26th 2015

An estimation of the direct healthcare and indirect work-loss cost burden of chronic HCV using health insurance claims covering 13 million individuals.

Read More

Site Logo

Rheumatoid Arthritis and Joint Replacement: Impact of Biologics

Guy David, PhD;Neeta Tandon, MA;Heidi C. Waters, MBA;Candace Gunnarsson, EdD;Arthur Kavanaugh, MD
December 16th 2014

Since the introduction of biologics to treat rheumatoid arthritis, there has been a reduction in total hip and total knee replacement surgeries among rheumatoid arthritis patients.

Read More

Latest Updated Articles

AI patient pharmacist provider interactions ASHP summer
Published: June 11th 2024 | Updated: July 27th 2024
Balancing Trust and Technology: The Role of AI in Patient-Pharmacist Interactions
AI pharmacy futures AI disparities skin
Published: June 11th 2024 | Updated: July 27th 2024
Addressing Disparities in AI-Driven Diagnostics: Ethical and Practical Implications
Vice President Kamala Harris -- Image credit: Erin Schaff/Pool/AFP | GETTY | People.com
Published: July 23rd 2024 | Updated: July 27th 2024
VP Kamala Harris’s Policies and Stances on Health Care, Reproductive Rights Take Center Stage
3d illustration of Abstract medical background with Diseased liver - Image credit: Rasi | stock.adobe.com
Published: October 18th 2023 | Updated: July 27th 2024
Pharmacists Can Optimize Treatment for Patients with NASH, Decreasing Economic Burden
Small vial of influenza vaccine.
Published: July 23rd 2024 | Updated: July 27th 2024
Trivalent Influenza Vaccines Are Readied for Fall
Eye Care Pharmacy | Image Credit: I Viewfinder - stock.adobe.com
Published: July 15th 2024 | Updated: July 27th 2024
Biosimilar Ranibizumab Could be More Cost-Effective Than Aflibercept for nAMD